40.1 C
New Delhi

Molnupiravir and Paxlovid , the heavily promoted antiviral drug ,Are they really safe ?

Date:

Share post:

So many new drugs come to the market and marketed as the panacea for the illness.
History reveals many such drugs had to be withdrawn due to toxicity.

If you have practiced medicine in the last 2 to 3 decades will remember many drugs that were withdrawn due to severe adverse effects.

Cisapride was used for heartburn,flatulence got withdrawn in 2003,it was shown to cause heart rhythm disturbances

Rofecoxib was a drug prescribed right and left for arthritic pain but later shown causing more heart attacks and thus withdrawn from the market.

This drug was marketed by Merck the same company promoting Molnupiravir the anti COVID pill which has been flagged up with problems specially to pregnant women and those planning to get pregnant

Terfenadine was used for allergy drug.It was withdrawn

Rosiglitazone an anti diabetic drug had 13,000 law suits as it was shown to cause more heart attacks.

When the modern Allopathy looks at Ayurveda as herbal medicine field,the reality is long list of medicines that were used heavily in allopathy but got withdrawn due to toxicities.

Why this post now?

Molnupiravir and Paxlovid two antiviral drugs promoted heavily for the COVID but we have to be cautious that no drug is safer and doctors should exercise caution in not going overboard to prescribe to everybody( an Indian phenomenon).

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

PM Modi’s Recent Visit to 5 European Countries and Their Outcome

Prime Minister Narendra Modi’s five-nation diplomatic tour in May 2026, which included the UAE and four European countries—the...

The Political Crusade of Suvendu Adhikari: Challenging the TMC on Corruption and Muslim Appeasement

In the high-octane theater of West Bengal politics, few figures command as much attention as Suvendu Adhikari. Once...

The Grand Recalibration: An Analysis of Trump’s May 2026 Visit to China and its Outcomes

In May 2026, the global political landscape was jolted by a scene few thought possible a year prior:...

Tata’s Strategic Alliance with ASML: A Giant Leap for the Indian Semiconductor Mission

The global semiconductor landscape is undergoing a tectonic shift. As nations race to secure their supply chains and...